Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Early hormones shape sex-specific differences in rat glands.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Alopecia X in dogs is a cosmetic issue, not a hormonal disorder, and harmful treatments should be avoided.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Agmatine may help reduce seizures linked to hormone changes in female rats.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.